CSPC Pharma Signs $18.5B AstraZeneca Deal for Weight Management Portfolio
CSPC Pharmaceutical Group Ltd (HKG: 1093) announced a landmark partnership with AstraZeneca Plc (AZ, NASDAQ: AZN) to...
Metabolic disease
Insilico Medicine Partners with Qilu Pharma on AI Drug Development
Insilico Medicine (HKG: 3696), a China‑based generative AI‑driven biotech, announced a strategic partnership with Qilu...
Ascletis Pharma Advances ASC37 Oral Triple Agonist for Obesity, Targets Q2 2026 FDA IND
Ascletis Pharma Inc. (HKG: 1672) announced it has selected ASC37 oral tablets, its first GLP‑1R/GIPR/GCGR...
Novo Nordisk’s Semaglutide 7.2 mg sNDA Submitted for Weight Management
Novo Nordisk A/S (NYSE: NVO) announced the submission of a supplemental New Drug Application (sNDA)...
CSPC’s JMT206 Wins NMPA Nod for ActRII-Targeted Weight Management
CSPC Pharmaceutical Group Limited (HKG: 1093) announced that its self‑developed recombinant fully human anti‑ActRIIA/IIB monoclonal...
SanegeneBio & Eli Lilly Sign Global Partnership to Advance RNAi Therapies for Metabolic Diseases
SanegeneBio, a biotechnology company specializing in RNAi therapeutics, today announced a global research collaboration and...